Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Target Price at $10.00

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has earned a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $9.88.

Several equities analysts recently commented on BIOX shares. Canaccord Genuity Group cut their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research note on Thursday. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research note on Friday, February 7th. Finally, Oppenheimer decreased their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 28th.

Institutional Trading of Bioceres Crop Solutions

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Fourth Sail Capital LP boosted its holdings in Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after purchasing an additional 527,859 shares in the last quarter. Long Focus Capital Management LLC grew its position in Bioceres Crop Solutions by 130.7% in the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock valued at $4,528,000 after acquiring an additional 421,931 shares during the period. Ballast Asset Management LP raised its stake in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after acquiring an additional 82,187 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Bioceres Crop Solutions by 17.0% during the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock valued at $640,000 after acquiring an additional 15,328 shares during the period. Finally, Stifel Financial Corp boosted its stake in shares of Bioceres Crop Solutions by 51.9% in the 4th quarter. Stifel Financial Corp now owns 61,958 shares of the company’s stock valued at $377,000 after purchasing an additional 21,168 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX opened at $4.96 on Friday. Bioceres Crop Solutions has a 12 month low of $4.42 and a 12 month high of $13.64. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The company has a market cap of $311.05 million, a P/E ratio of 248.12 and a beta of 0.57. The business’s 50 day moving average is $6.49 and its two-hundred day moving average is $7.66.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.